Clinical relevance analysis revealed that IGF2BP2 and IGF2BP3 were significantly upregulated in ESCC and IGF2BP2 was a potential prognostic biomarker in ESCC. The gene discussed is IGF2BP3; the disease is esophageal squamous cell carcinoma.